Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical Significance of Spatial Heterogeneity in Newly Diagnosed and Relapsed Multiple Myeloma

Blood (2021) 138 (Supplement 1): 1607.

https://doi.org/10.1182/blood-2021-152427

Published: 2021

Journal Articles

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142622

Published: 2020

Journal Articles

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation

Blood (2018) 131 (22): 2490–2499.

https://doi.org/10.1182/blood-2017-11-817973

Published: 2018

Includes: Supplemental data

Journal Articles

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Blood (2017) 130 (13): 1585–1596.

https://doi.org/10.1182/blood-2017-05-784637

Published: 2017

Includes: Supplemental data

Journal Articles

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Qianqian Zhu#, PhD, Li Yan#, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Kenan Onel, MD PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Song Liu, PhD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 518.

https://doi.org/10.1182/blood.V128.22.518.518

Published: 2016

Journal Articles

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Alyssa I. Clay, PhD, Theresa Hahn, PhD, Qianqian Zhu, PhD, Li Yan, PhD, Leah Preus, MS, Daniel O. Stram, PhD, Christopher A. Haiman, ScD, Loreall C. Pooler, MS, Xin Sheng, MS, Kenan Onel, MD PhD, Qian Liu, MA, Qiang Hu, PhD, Song Liu, PhD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 42.

https://doi.org/10.1182/blood.V128.22.42.42

Published: 2016

Journal Articles

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Ezgi Karaesmen#, MS, Abbas Rizvi#, MS, Qianqian Zhu, PhD, Li Yan, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Song Liu, PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 71.

https://doi.org/10.1182/blood.V128.22.71.71

Published: 2016

Journal Articles

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Blood (2016) 128 (20): 2450–2456.

https://doi.org/10.1182/blood-2016-07-728063

Published: 2016

Includes: Supplemental data

Journal Articles

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo

Natalie M. Czuczman, Matthew J. Barth, Juan Gu, Vishala Neppalli, Cory Mavis, Sarah E. Frys, Qiang Hu, Song Liu, Pavel Klener, Petra Vockova, Myron S. Czuczman, Francisco J. Hernandez-Ilizaliturri

Blood (2016) 127 (9): 1128–1137.

https://doi.org/10.1182/blood-2015-04-640920

Published: 2016

Includes: Supplemental data

Journal Articles

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 61.

https://doi.org/10.1182/blood.V126.23.61.61

Published: 2015

Journal Articles

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 397.

https://doi.org/10.1182/blood.V126.23.397.397

Published: 2015

Journal Articles

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Blood (2015) 126 (23): 2621.

https://doi.org/10.1182/blood.V126.23.2621.2621

Published: 2015

Journal Articles

Patients Treated With Decitabine Demonstrate Changes In β-Catenin Localization From The Nucleus To The Cytoplasm In Circulating Blasts

Michelle Golding, Benjamin E Paluch, BS, Pragya Srivastava, PhD, Song Liu, PhD, Qiang Hu, PhD, Meir Wetzler, MD, Michael Nemeth, Elizabeth A. Griffiths, MD

Blood (2013) 122 (21): 3956.

https://doi.org/10.1182/blood.V122.21.3956.3956

Published: 2013

Journal Articles

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Sudha Mannava, DaZhong Zhuang, Jayakumar R. Nair, Rajat Bansal, Joseph A. Wawrzyniak, Shoshanna N. Zucker, Emily E. Fink, Kalyana C. Moparthy, Qiang Hu, Song Liu, Lawrence H. Boise, Kelvin P. Lee, Mikhail A. Nikiforov

Blood (2012) 119 (6): 1450–1458.

https://doi.org/10.1182/blood-2011-04-346676

Published: 2012

Includes: Supplemental data

NARROW

Clinical Significance of Spatial Heterogeneity in Newly Diagnosed and Relapsed Multiple Myeloma

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation

Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Patients Treated With Decitabine Demonstrate Changes In β-Catenin Localization From The Nucleus To The Cytoplasm In Circulating Blasts

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only